鼻腔给药
固体脂质纳米粒
生物利用度
化学
药理学
神经保护
药物输送
输送系统
纳米颗粒
脂质体
纳米技术
色谱法
生物相容性材料
材料科学
作者
Yogesh Ashok Sonar,Devyani Mahajan,Eknath B. Kole,Rakesh B. Daude,Jitendra Naik,Bhushan Ashok Bhairav
标识
DOI:10.1080/20415990.2025.2594295
摘要
Aims To develop and evaluate α-Cyperone (α-Cy)-loaded solid lipid nanoparticles (SLNs) incorporated into a thermosensitive in situ gel for enhanced intranasal delivery and improved neuroprotective efficacy.Materials and methods α-Cy-SLN was prepared using high-pressure homogenization followed by freeze-drying. The formulation was optimized using a Box-Behnken Design, assessing the effects of lipid-to-surfactant ratio on particle size, polydispersity index (PDI), zeta potential, and entrapment efficiency (EE). The optimized SLNs were characterized for physicochemical properties, in vitro drug release, and brain cell penetration.Results The optimized α-Cy-SLNs (Run 5) exhibited a mean particle size of 279.5 ± 0.06 nm, PDI of 0.203 ± 0.24, zeta potential of −23.1 ± 2.38 mV, EE of 70.0 ± 2.21%, and product yield of 72.58 ± 1.24%. In vitro studies demonstrated a sustained release of α-Cy from the SLNs, indicating the formulation’s potential for prolonged drug delivery. Incorporation into the thermosensitive in situ gel further supported controlled release and enhanced bioavailability.Conclusions The developed α-Cy-SLN in situ gel formulation offers a promising strategy for intranasal delivery, improving α-Cy bioavailability and therapeutic potential for neuroprotection in Alzheimer’s disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI